view low-bandwidth site

Autoimmune Disease

Wave 80's high-performance technology for autoimmune disease allows rapid, multiplexed quantitation of key targets, with excellent reproducibility across enclosed cartridge and microplate formats. The lead pipeline product is in type 1 diabetes.

  • AUTOANTIBODY DETECTION AND QUANTITATION.
    A unique signaling system improves markedly on legacy methods.
  • MULTIPLEXING.
    Four or more targets measured simultaneously.